Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Surein Arulananda

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|October 10, 2022
Minimal residual disease in <i>EGFR</i>-mutant non-small-cell lung cancerNathan T Bain, Yang Wang, Surein Arulananda
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 10, 2018
In Reply to LeoneHongdo Do, Surein Arulananda, Thomas John, et al.
Internal Medicine Journal|December 7, 2019
RET-rearranged non-small-cell lung cancer and therapeutic implicationsZoe Loh, Paul Mitchell, Thomas John, et al.
Translational Lung Cancer Research|March 18, 2024
Osimertinib in uncommon <i>EGFR</i> exon 21 L861R and <i>EGFR</i> exon 18 deletion-insertion mutant non-small cell lung cancer-case reportYang Wang, Pranav Dorwal, Suraindra Rajadurai, et al.
Expert Review of Anticancer Therapy|November 26, 2020
The role of BCL-2 family proteins and therapeutic potential of BH3-mimetics in malignant pleural mesotheliomaSurein Arulananda, Erinna F Lee, W Douglas Fairlie, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 16, 2011
Bronchoepidural Fistula in a man with actinomycosis complicated non-small cell lung cancerMun Sem Liew, Surein Arulananda, James Seow, et al.
Journal of Thoracic Disease|April 11, 2020
Management of non-small cell lung cancer with resistance to epidermal growth factor receptor tyrosine kinase inhibitor: case discussionYuyan Zheng, Min Zhou, Surein Arulananda, et al.
The Australasian Journal of Dermatology|June 8, 2012
Pulmonary metastases: a rare manifestation of the most common cancerSurein Arulananda, Mun Sem Liew, Shane Battye, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 28, 2017
Combination Osimertinib and Gefitinib in C797S and T790M EGFR-Mutated Non-Small Cell Lung CancerSurein Arulananda, Hongdo Do, Ashan Musafer, et al.
Cancer Reports (Hoboken, N.J.)|July 29, 2020
A pilot study of intrahepatic yttrium-90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver-only metastasesSurein Arulananda, Sagun Parakh, Jodie Palmer, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|October 10, 2022
Minimal residual disease in <i>EGFR</i>-mutant non-small-cell lung cancerNathan T Bain, Yang Wang, Surein Arulananda
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 10, 2018
In Reply to LeoneHongdo Do, Surein Arulananda, Thomas John, et al.
Internal Medicine Journal|December 7, 2019
RET-rearranged non-small-cell lung cancer and therapeutic implicationsZoe Loh, Paul Mitchell, Thomas John, et al.
Translational Lung Cancer Research|March 18, 2024
Osimertinib in uncommon <i>EGFR</i> exon 21 L861R and <i>EGFR</i> exon 18 deletion-insertion mutant non-small cell lung cancer-case reportYang Wang, Pranav Dorwal, Suraindra Rajadurai, et al.
Expert Review of Anticancer Therapy|November 26, 2020
The role of BCL-2 family proteins and therapeutic potential of BH3-mimetics in malignant pleural mesotheliomaSurein Arulananda, Erinna F Lee, W Douglas Fairlie, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 16, 2011
Bronchoepidural Fistula in a man with actinomycosis complicated non-small cell lung cancerMun Sem Liew, Surein Arulananda, James Seow, et al.
Journal of Thoracic Disease|April 11, 2020
Management of non-small cell lung cancer with resistance to epidermal growth factor receptor tyrosine kinase inhibitor: case discussionYuyan Zheng, Min Zhou, Surein Arulananda, et al.
The Australasian Journal of Dermatology|June 8, 2012
Pulmonary metastases: a rare manifestation of the most common cancerSurein Arulananda, Mun Sem Liew, Shane Battye, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 28, 2017
Combination Osimertinib and Gefitinib in C797S and T790M EGFR-Mutated Non-Small Cell Lung CancerSurein Arulananda, Hongdo Do, Ashan Musafer, et al.
Cancer Reports (Hoboken, N.J.)|July 29, 2020
A pilot study of intrahepatic yttrium-90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver-only metastasesSurein Arulananda, Sagun Parakh, Jodie Palmer, et al.
Pageof 5